Safety and Efficacy of Bioabsorbable Drug-Eluting Sinus Implant for Chronic Sinusitis (RESOLVE)
This study has been completed.
Information provided by (Responsible Party):
First received: November 14, 2012
Last updated: January 18, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||May 2014|
|Primary Completion Date:||November 2013 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Received:||March 5, 2015|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Han JK, Forwith KD, Smith TL, Kern RC, Brown WJ, Miller SK, Ow RA, Poetker DM, Karanfilov B, Matheny KE, Stambaugh J, Gawlicka AK. RESOLVE: a randomized, controlled, blinded study of bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis. Int Forum Allergy Rhinol. 2014 Nov;4(11):861-70. doi: 10.1002/alr.21426.